Butorphanol Tartrate
2 NDCs across 2 manufacturers|2 Generic,0 Brand
Butorphanol Tartrate is used to treat pain, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 22, 1997. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $2 million on Butorphanol Tartrate across 24,000 claims for 2,603 beneficiaries.
Butorphanol Tartrate is available as 2 NDCs from 2 manufacturers (2 generic, 0 brand), with NADAC prices from $15.46 to $15.46 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
2G / 0B
Manufacturers
2
competing in market
Price Spread
$15.46 – $15.46
per ML
7d Activity
avg -0.5% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Hikma Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Opioid Agonist/Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing BUTORPHANOL TARTRATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BUTORPHANOL 10 MG/ML SPRAY | $15.4598 per ML | -0.52% |
BUTORPHANOL 10 MG/ML SPRAY | $15.4598 per ML | -0.52% |
Frequently Asked Questions
What is Butorphanol Tartrate used to treat?
Butorphanol Tartrate is used to treat pain, per the National Library of Medicine's MED-RT classification.
When did Butorphanol Tartrate become available as a generic?
FDA approved the first generic Butorphanol Tartrate (ANDA) on Jan 22, 1997. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Butorphanol Tartrate?
In 2024, Medicare Part D spent $2 million on Butorphanol Tartrate across 24,000 claims for 2,603 beneficiaries.
How many Butorphanol Tartrate products are on the market?
The Butorphanol Tartrate drug market contains 2 NDCs from 2 manufacturers — 2 generic and 0 brand products.
What is the price range for Butorphanol Tartrate?
NADAC reference prices for Butorphanol Tartrate range from $15.4598 to $15.4598 per ML.
Which manufacturers make Butorphanol Tartrate?
2 manufacturers list Butorphanol Tartrate in NADAC. Ranked by number of NDCs, the largest are Hikma Pharmaceuticals USA Inc. (1), Apotex Corp. (1).
How has the price of Butorphanol Tartrate changed recently?
Over the past 7 days, 0 Butorphanol Tartrate NDCs rose and 2 fell, with a market-wide average change of -0.5%.